Clinical and Pharmacological Considerations for Concomitant Administration of Posaconazole and Isavuconazole with Letermovir

MLA

Terrier, Jean, et al. “Clinical and Pharmacological Considerations for Concomitant Administration of Posaconazole and Isavuconazole with Letermovir.” Antimicrobial Agents and Chemotherapy, vol. 65, no. 6, Jan. 2021, pp. e00274-21. EBSCOhost, https://doi.org/10.1128/AAC.00274-21.

APA

Terrier, J., Zanella, M.-C., Masouridi-Levrat, S., Kronig, I., Chalandon, Y., Vernaz, N., Van Delden, C., Papanicolaou, G., & Neofytos, D. (2021). Clinical and Pharmacological Considerations for Concomitant Administration of Posaconazole and Isavuconazole with Letermovir. Antimicrobial Agents and Chemotherapy, 65(6), e00274-21. https://doi.org/10.1128/AAC.00274-21

Chicago

Terrier, Jean, Marie-Céline Zanella, Stavroula Masouridi-Levrat, Ilona Kronig, Yves Chalandon, Nathalie Vernaz, Christian Van Delden, Genovefa Papanicolaou, and Dionysios Neofytos. 2021. “Clinical and Pharmacological Considerations for Concomitant Administration of Posaconazole and Isavuconazole with Letermovir.” Antimicrobial Agents and Chemotherapy 65 (6): e00274-21. doi:10.1128/AAC.00274-21.